Purpose: To evaluate the effectiveness of hemoglobin A1c (HbA1C), fructosamine, and glycated albumin (GA) in assessing glycemic control among type II diabetic patients with end-stage renal disease (ESRD) on regular hemodialysis. Methods: This cross-sectional observational study was conducted on 90 type II diabetic ESRD patients on regular hemodialysis and were classified into good and poor glycemic control based on 8 point glucose testing. Good control required 70% of pre-prandial readings below 130 mg/dl, 70% of post-prandial readings below 180 mg/dl, and glycemic variability under 50 in more than 70% of readings. Based on these criteria, 40% had good control, while 60% had poor control.